Department of Health

RhD immunoglobulin (Ig) in obstetrics audit report 2018

RhD immunoglobulin is used to prevent RhD alloimmunisation and subsequent haemolytic disease of the newborn in RhD negative women. It has been available in Australia since 1967.

The Blood Matters serious transfusion incident reporting (STIR) system has collected information on incidents, reactions and near misses relating to transfusion since 2007. Since reporting commenced, some common error themes emerged.

To understand current practice, Blood Matters conducted an audit to assess compliance with the current Australian guidelines.


Research and reports
Date published
21 Aug 2019
33 pages

Reviewed 22 August 2019

Was this page helpful?